American Kidney Fund Announces Partnership with Tricida to Expand Education of Metabolic Acidosis in Patients with Kidney Disease

Press release content from Accesswire. The AP news staff was not involved in its creation.

ROCKVILLE, MD / ACCESSWIRE / October 22, 2020 / The American Kidney Fund (AKF) today announced a partnership with Tricida, Inc. to increase the understanding of chronic metabolic acidosis, a common complication of kidney disease that can cause serious effects, such as chronic kidney disease (CKD) progression, muscle atrophy and cardiac issues. Tricida’s support will allow AKF to develop and disseminate educational information about metabolic acidosis’ role in the progression of CKD.

“Complications of CKD, such as metabolic acidosis, create serious health problems, including patients’ kidney disease getting worse,” said LaVarne A. Burton, AKF president and CEO. “We are extraordinarily grateful to Tricida for its partnership in working with us to encourage patients to take metabolic acidosis management seriously.”

“Tricida is honored to partner with the American Kidney Fund on this

Read More